Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT.

CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. Review.

2.

Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior.

Chen A, Zorrilla E, Smith S, Rousso D, Levy C, Vaughan J, Donaldson C, Roberts A, Lee KF, Vale W.

J Neurosci. 2006 May 17;26(20):5500-10.

3.

Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.

Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ.

Biol Psychiatry. 2007 Jan 15;61(2):187-97.

PMID:
16697351
4.

Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.

Crowley JJ, Brodkin ES, Blendy JA, Berrettini WH, Lucki I.

Neuropsychopharmacology. 2006 Nov;31(11):2433-42.

5.

Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease.

Glatt C, Almonte M, Taylor T, Edwards RH, Freimer N, Tanner C; Parkinson Study Group..

Mov Disord. 2006 Mar;21(3):426-7. No abstract available.

PMID:
16450345
6.

Bupropion increases striatal vesicular monoamine transport.

Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.

Neuropharmacology. 2005 Nov;49(6):820-30.

PMID:
16005476
7.

Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hörtnagl H, Flor H, Henn FA, Schütz G, Gass P.

J Neurosci. 2005 Jun 29;25(26):6243-50.

8.
9.

Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Dulawa SC, Hen R.

Neurosci Biobehav Rev. 2005;29(4-5):771-83. Review.

PMID:
15890403
10.

Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.

Pogorelov VM, Rodriguiz RM, Insco ML, Caron MG, Wetsel WC.

Neuropsychopharmacology. 2005 Oct;30(10):1818-31.

11.

SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.

Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR.

Hum Mol Genet. 2005 May 15;14(10):1393-404.

12.
13.

ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory.

Grove M, Demyanenko G, Echarri A, Zipfel PA, Quiroz ME, Rodriguiz RM, Playford M, Martensen SA, Robinson MR, Wetsel WC, Maness PF, Pendergast AM.

Mol Cell Biol. 2004 Dec;24(24):10905-22.

14.

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.

Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA.

Science. 2004 Oct 29;306(5697):879-81.

15.

The effect of rare human sequence variants on the function of vesicular monoamine transporter 2.

Burman J, Tran CH, Glatt C, Freimer NB, Edwards RH.

Pharmacogenetics. 2004 Sep;14(9):587-94.

PMID:
15475732
16.

Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability.

Wei Q, Lu XY, Liu L, Schafer G, Shieh KR, Burke S, Robinson TE, Watson SJ, Seasholtz AF, Akil H.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11851-6.

17.

Importance of studying the contributions of early adverse experience to neurobiological findings in depression.

Heim C, Plotsky PM, Nemeroff CB.

Neuropsychopharmacology. 2004 Apr;29(4):641-8. Review.

18.

Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.

Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA.

Biol Psychiatry. 2003 Nov 15;54(10):960-71.

PMID:
14625138
19.

Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

FREIS ED.

N Engl J Med. 1954 Dec 16;251(25):1006-8. No abstract available.

PMID:
13214379
20.

Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice.

Merali Z, Levac C, Anisman H.

Biol Psychiatry. 2003 Sep 1;54(5):552-65.

PMID:
12946884
Items per page

Supplemental Content

Support Center